Late Phase Clinical Trials
Refine--and redefine--research objectives at registration and beyond
With Quintiles as your partner, you can address ever-evolving post-market environments with ease. We can help you develop and implement strategies to meet increasing stakeholder requirements and position your product for better market access, expanded labeling and more.
Quintiles has delivered more than 530 Real-World & Late Phase Programs involving more than 74,000 sites and more than 650,000 enrolled patients in more than 100 countries since 2011.